Controversial Diet Pill Featured At Conference

FACT: The AND allows pharmaceutical companies to market their controversial products at AND events.
At the 2007 ADA Food & Nutrition Conference & Expo, GlaxoSmithKline was allowed to promote their first over-the-counter diet pill, Alli, even though the drug’s weight loss effectiveness is minimal and side effects such as hard-to-control bowel movements and anal discharge are common. The FDA has since issued warnings to Alli, noting the possibly of severe liver damage, and consumer groups are asking the FDA to remove Alli from the market.

Source: http://www.inthesetimes.com/article/3447/corporate_potluck